PM&R accepted for abstracting and indexing ...( Philadelphia PA July 8 2009 Elsevie...),Health
Philadelphia, PA, July 8, 2009 Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that PM&R -The journal of injury, function and rehabilitation (www.pmrjournal.org), the official scientific journal of the American Academy of Physical Medicine and Rehabilitation (AAPM&R), has been accepted for coverage by MEDLINE, just six months after its launch in January 2009.
Under the guidance of Editor-in-Chief Stuart M. Weinstein, MD, Clinical Professor of Rehabilitation Medicine at the University of Washington, Seattle, and an internationally renowned Editorial Board, this monthly, peer-reviewed, scholarly publication has a clinical focus, presenting an array of topics pertinent to physiatrists (rehabilitation medicine physicians), to those in other related medical disciplines, as well as to a wider international readership.
"It is particularly gratifying that a fledgling journal such as PM&R has already been recognized for its contribution to the advancement of physical medicine and rehabilitation," commented Dr. Weinstein. "Working in close partnership with the AAPM&R it is our goal to raise the scientific bar and build bridges between practitioners and researchers across this multidisciplinary field. I am thankful to the entire editorial and publishing team who have committed to the success of this journal."
MEDLINE abstracting and indexing of PM&R will start as soon as possible and will be retroactive to Volume 1/Issue 1. MEDLINE is the U.S. National Library of Medicine's premier bibliographic database containing over 16 million references to journal articles in life sciences with a concentration on biomedicine. PM&R was evaluated and selected for inclusion based on a stringent review process conducted by the Literature Selection Technical Review Committee, an NIH-chartered advisory committee
'/>"/>
| Contact: Herb Niemirow h.niemirow@elsevier.com 212-633-3141 Elsevier Health Sciences Source:Eurekalert |
Related medicine news :
1. Elsevier announces launch of PM&R in partnership with the AAPM&R
2. ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
3. Four Abstracts by Biopure and Collaborating Scientists Accepted for Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
4. American Journal of Disaster Medicine Accepted for Inclusion into The National Library of Medicines MEDLINE Database and may now be Accessed Through the PUBMED Website or the MEDLARS System
5. Orqis(R) Medicals MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting
6. Phyhealth HMO Applications Accepted by All Required Federal and State Agencies
7. Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27
8. LIFE FOR A CHILD Diabetes Documentary Accepted Into Competition at New Yorks Prestigious Tribeca Film Festival
9. Market Research Shows Spherixs Naturlose(R) Readily Accepted by Diabetes Patients
10. Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing by FDA for the Treatment of Overactive Bladder
11. Nominations Accepted for 2008 Champions of Health Awards
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |